Clinical Trial Update: Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term analgesic efficacy and safety of tanezumab alone or with NSAIDs versus NSAIDs alone in knee or hip osteoarthritis arthritis; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis, Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-06-24